A new thematic series in Malaria Journal: Ivermectin to reduce malaria transmission

https://www.biomedcentral.com/collections/ivermectinmalaria

Hundreds of millions of people have received ivermectin every year in campaigns against onchocerciasis and lymphatic filariasis with excellent safety profile. It is also an endectocide, a drug capable of killing mosquitoes feeding on treated subjects. In the face of the challenges posed by insecticide resistance and residual transmission, mass drug administration of endectocides holds potential as a complementary strategy for malaria elimination. This ‘Ivermectin to reduce malaria transmission’ thematic series in the Malaria Journal aims at providing a comprehensive assessment and factors to consider in adapting this tool for a potential new indication.

(Visited 8 times, 1 visits today)
This entry was posted in Essential Medicines, General, Malaria, Other Infectious Diseases. Bookmark the permalink.